Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review

Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceuticals, generic pharmaceuticals, sterile injectables and other products through its operating companies. It sells generic products in the US in various categories including urology, pain management, central nervous system (CNS) disorders, immunosuppression, cancer, cardiovascular diseases and women’s health. The company offers branded pharmaceuticals for conditions related to urology, orthopedics, endocrine disorders and pain management. Endo also provides over-the-counter (OTC) products, which include dermatological products and anti-infectives. The company sells its products through independent wholesale distributors to retailers, government agencies, doctors, clinics, independent retail and specialty pharmacies and independent specialty distributors. Endo is headquartered in Dublin, Ireland.

Endo International Plc Key Recent Developments

May 05,2022: ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS
Apr 20,2022: Tennessee Court of appeals orders recusal of trial court judge and vacates default judgment on liability against Endo
Mar 03,2022: Endo launches New Living Our Values Program to recognize outstanding team members
Feb 28,2022: Endo reports fourth-quarter and full-year 2021 financial results
Jan 18,2022: Endo reaches agreement intended to settle Florida governmental opioid cases and claims

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Endo International Plc - Key Facts
Endo International Plc - Key Employees
Endo International Plc - Key Employee Biographies
Endo International Plc - Major Products and Services
Endo International Plc - History
Endo International Plc - Company Statement
Endo International Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Endo International Plc - Business Description
Business Segment: Branded Pharmaceuticals
Overview
Performance
Business Segment: Generic Pharmaceuticals
Overview
Performance
Business Segment: International Pharmaceuticals
Overview
Performance
Business Segment: Sterile Injectables
Overview
Performance
R&D Overview
Endo International Plc - Corporate Strategy
Endo International Plc - SWOT Analysis
SWOT Analysis - Overview
Endo International Plc - Strengths
Endo International Plc - Weaknesses
Endo International Plc - Opportunities
Endo International Plc - Threats
Endo International Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
Endo International Plc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
Endo International Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 05, 2022: ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS
Apr 20, 2022: Tennessee Court of appeals orders recusal of trial court judge and vacates default judgment on liability against Endo
Mar 03, 2022: Endo launches New Living Our Values Program to recognize outstanding team members
Feb 28, 2022: Endo reports fourth-quarter and full-year 2021 financial results
Jan 18, 2022: Endo reaches agreement intended to settle Florida governmental opioid cases and claims
Jan 11, 2022: Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Development
Dec 24, 2021: Endo enters settlement agreement to resolve opioid claims in Texas
Dec 15, 2021: Endo announces favorable final ruling in California State court opioid trial
Nov 17, 2021: Endo announces Fill-Finish manufacturing agreement with U.S. Government to support production of critical medicines
Nov 04, 2021: Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Endo International Plc, Key Facts
Endo International Plc, Key Employees
Endo International Plc, Key Employee Biographies
Endo International Plc, Major Products and Services
Endo International Plc, History
Endo International Plc, Other Locations
Endo International Plc, Subsidiaries
Endo International Plc, Key Competitors
Endo International Plc, Ratios based on current share price
Endo International Plc, Annual Ratios
Endo International Plc, Annual Ratios (Cont...1)
Endo International Plc, Annual Ratios (Cont...2)
Endo International Plc, Interim Ratios
Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
Endo International Plc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
Endo International Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Endo International Plc, Performance Chart (2017 - 2021)
Endo International Plc, Ratio Charts
Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
Endo International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings